Kestra expects $137M FY2027 revenue while targeting 70%+ gross margins in the next few years
Seeking Alpha ·
Earnings Call Insights: Kestra Medical Technologies (KMTS) Q4 fiscal 2026 "We concluded fiscal 2026 with another strong quarter" and "Revenue was $28.6 million" alongside "over 6,300 prescriptions written for the ASSURE system," Brian Webster said (Founder, President, CEO & Director Brian Webster).
DYAX Investor Sentiment
Bullish (Long) 50% · Bearish (Short) 50%
585 participants
Related News
- Why Salesforce Stock Slumped on Tuesday
- LNG Canada offers First Nations option to invest up to C$1B in phase 2 project
- Why Palo Alto Networks Stock Zoomed Almost 7% Higher Today
- Oil eases off day's highs after Trump nixes proposed 20% Strait of Hormuz transit fee
- The banker is coming back, and AI is the reason
- 전기료 급등 가능성에 美뉴욕주, 대형 데이터센터 신축 1년 미루기로